Abnormal Glucose Regulation and Treatment Strategies for Insulin Resistance HIV-Infected Patients

被引：1

作者：

Grinspoon, Steven ^{[1
,2
]}

机构：

[1] Mass Gen Hosp, Program Nutrit Metab, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF INFECTIOUS DISEASES | 2006年 / 2卷 / 03期

关键词：

HIV-infected patients; abnormalities; insulin resistance; glucose regulation;

D O I：

10.3844/ajidsp.2006.184.186

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

HIV-infected patients receiving highly active antiretroviral therapy often demonstrate abnormalities in glucose regulation, in association with changes in fat distribution([1,2]). In the majority of cases, these abnormalities are best characterized by insulin resistance and impaired glucose tolerance, rather than overt diabetes mellitus and fasting hyperglycemia. Insulin resistance may result from direct effects of antiretroviral therapy, changes in fat distribution or abnormal regulation of fat metabolism and adipocytokines. Use of insulin sensitizing agents may be rationale to reduce cardiovascular risk and improve related metabolic and body fat abnormalities in HIV-infected patients.

引用

页码：184 / 186

页数：3

共 23 条

[1] Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].

Arioglu, E ;

Duncan-Morin, J ;

Sebring, N ;

Rother, KI ;

Gottlieb, N ;

Lieberman, J ;

Herion, D ;

Kleiner, DE ;

Reynolds, J ;

Premkumar, A ;

Sumner, AE ;

Hoofnagle, J ;

Reitman, ML ;

Taylor, SI .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274

[2] Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance [J].

Bastard, JP ;

Caron, M ;

Vidal, H ;

Jan, V ;

Auclair, M ;

Vigouroux, C ;

Luboinski, J ;

Laville, M ;

Malachi, M ;

Girard, PM ;

Rozenbaum, W ;

Levan, P ;

Capeau, J .

LANCET, 2002, 359 (9311) :1026-1031

[3]

BROWN TT, 2004, 11 C RETR OPP INF SA

[4] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[5] No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial [J].

Carr, A ;

Workman, C ;

Carey, D ;

Rogers, G ;

Martin, A ;

Baker, D ;

Wand, H ;

Law, M ;

Samaras, K ;

Emery, S ;

Cooper, DA .

LANCET, 2004, 363 (9407) :429-438

[6] Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].

Despres, JP ;

Lamarche, B ;

Mauriege, P ;

Cantin, B ;

Dagenais, GR ;

Moorjani, S ;

Lupien, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957

[7] Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients [J].

Driscoll, SD ;

Meininger, GE ;

Lareau, MT ;

Dolan, SE ;

Killilea, KM ;

Hadigan, CM ;

Lloyd-Jones, DM ;

Klibanski, A ;

Frontera, WR ;

Grinspoon, SK .

AIDS, 2004, 18 (03) :465-473

[8] Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients [J].

Driscoll, SD ;

Meininger, GE ;

Ljungquist, K ;

Hadigan, C ;

Torriani, M ;

Klibanski, A ;

Frontera, WR ;

Grinspoon, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2171-2178

[9]

ESCHWEGE E, 1985, HORM METAB RES, V15, P41

[10] Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: A pilot study [J].

Gelato, MC ;

Mynarcik, DC ;

Quick, JL ;

Steigbigel, RT ;

Fuhrer, J ;

Brathwaite, CEM ;

Brebbia, JS ;

Wax, MR ;

McNurlan, MA .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) :163-170

← 1 2 3 →